BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Coleman HG, Bhat S, Murray LJ, McManus D, Gavin AT, Johnston BT. Increasing incidence of Barrett’s oesophagus: a population-based study. Eur J Epidemiol. 2011;26:739-745. [PMID: 21671079 DOI: 10.1007/s10654-011-9596-z] [Cited by in Crossref: 82] [Cited by in F6Publishing: 64] [Article Influence: 6.8] [Reference Citation Analysis]
Number Citing Articles
1 Holmberg D, Lagergren J. Epidemiology of Barrett’s Esophagus and Esophageal Adenocarcinoma. Foregut: The Journal of the American Foregut Society 2022. [DOI: 10.1177/26345161221138045] [Reference Citation Analysis]
2 Copetti H, Copetti L, Copetti L, Felin GD, Felin GD, Felin CD, Felin FD, Chiesa V. RISK OF PRENEOPLASTIC LESIONS IN MUCOSAL PROJECTIONS OF DIFFERENT SIZES OF THE COLUMNAR EPITHELIUM IN THE LOWER ESOPHAGUS. Arq Bras Cir Dig 2022;35:e1674. [PMID: 36102485 DOI: 10.1590/0102-672020220002e1674] [Reference Citation Analysis]
3 Wang SE, Hodge A, Dashti SG, Dixon-suen SC, Castaño-rodríguez N, Thomas R, Giles G, Boussioutas A, Kendall B, English DR. Diet and risk of Barrett’s oesophagus: Melbourne collaborative cohort study. Br J Nutr 2022. [DOI: 10.1017/s0007114522002112] [Reference Citation Analysis]
4 Stephanie M, Nour H, de Sá Inês M, Shanker K, Kevin K, Mario DR, Prateek S. Gender differences in Barrett's esophagus and progression of disease: a systematic review and meta-analysis. Dis Esophagus 2022;35:doab075. [PMID: 34761256 DOI: 10.1093/dote/doab075] [Reference Citation Analysis]
5 Westphalen C, Quante M, Söhlke B, Wartenberg M, Knauf W, Illmer T, Gökkurt E, Tannapfel A, Griesinger F, Reinacher-schick A, Loges S. Sektorenübergreifende interdisziplinäre Zusammenarbeit der Arbeitsgemeinschaft Internistische Onkologie in der Präzisionsonkologie. Onkologe 2022;28:6-16. [DOI: 10.1007/s00761-021-01090-8] [Reference Citation Analysis]
6 Wang SE, Kendall BJ, Hodge AM, Dixon-Suen SC, Dashti SG, Makalic E, Williamson EM, Thomas RJS, Giles GG, English DR. Demographic and lifestyle risk factors for gastroesophageal reflux disease and Barrett's esophagus in Australia. Dis Esophagus 2022;35:doab058. [PMID: 34409990 DOI: 10.1093/dote/doab058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Pokala SK, Jones B, Wani S. Quality in Advanced Endoscopy. Techniques and Innovations in Gastrointestinal Endoscopy 2022;24:300-308. [DOI: 10.1016/j.tige.2022.01.004] [Reference Citation Analysis]
8 Zhang Z, Curran G, Altinok Dindar D, Wu Y, Wu H, Sharpton T, Zhao L, Lieberman D, Otaki F. Insights Into the Oral Microbiome and Barrett's Esophagus Early Detection: A Narrative Review. Clin Transl Gastroenterol 2021;12:e00390. [PMID: 34446641 DOI: 10.14309/ctg.0000000000000390] [Reference Citation Analysis]
9 Elias PS, Spechler SJ. Barrett's Esophagus. The Esophagus 2021. [DOI: 10.1002/9781119599692.ch29] [Reference Citation Analysis]
10 Twohig-Bennett L, Coleman HG, Cairnduff V, McManus DT, Murray LJ, Gavin AT, Johnston BT. Esophageal Columnar Metaplasia in Childhood: A Population-Based Case Series Analysis. Dig Dis Sci 2021;66:2317-22. [PMID: 32683588 DOI: 10.1007/s10620-020-06462-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Kunzmann AT, Coleman HG, Johnston BT, Turkington RC, McManus D, Anderson LA, Thrift AP. Does Risk of Progression from Barrett's Esophagus to Esophageal Adenocarcinoma Change Based on the Number of Non-dysplastic Endoscopies? Dig Dis Sci 2021;66:1965-73. [PMID: 32734400 DOI: 10.1007/s10620-020-06483-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Allen JE, Desai M, Roumans CAM, Vennalaganti S, Vennalaganti P, Bansal A, Falk G, Lieberman D, Sampliner R, Thota P, Vargo J, Gupta N, Moawad F, Bruno M, Kennedy KF, Gaddam S, Young P, Mathur S, Cash B, Spaander M, Sharma P. Low Risk of Progression of Barrett's Esophagus to Neoplasia in Women. J Clin Gastroenterol 2021;55:321-6. [PMID: 32379085 DOI: 10.1097/MCG.0000000000001362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Attia H, Smyth E. Evolving therapies in advanced oesophago-gastric cancers and the increasing role of immunotherapy. Expert Rev Anticancer Ther 2021;21:535-46. [PMID: 33349073 DOI: 10.1080/14737140.2021.1866548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
14 Zagari RM, Eusebi LH, Galloro G, Rabitti S, Neri M, Pasquale L, Bazzoli F. Attending Training Courses on Barrett's Esophagus Improves Adherence to Guidelines: A Survey from the Italian Society of Digestive Endoscopy. Dig Dis Sci 2021;66:2888-96. [PMID: 32984930 DOI: 10.1007/s10620-020-06615-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
15 Chuy J, Kornblum N. Esophageal Cancer. Geriatric Gastroenterology 2021. [DOI: 10.1007/978-3-030-30192-7_78] [Reference Citation Analysis]
16 Jones B, Wani S. Endoscopic Eradication Therapy for Barrett's Neoplasia: Where Do We Stand a Decade Later? Curr Gastroenterol Rep 2020;22:61. [PMID: 33277663 DOI: 10.1007/s11894-020-00799-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Cook MB, Thrift AP. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma: Implications for Screening and Surveillance. Gastrointest Endosc Clin N Am 2021;31:1-26. [PMID: 33213789 DOI: 10.1016/j.giec.2020.08.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
18 Quante M. BarrettNET – Risikoevaluation und Prävention von Adenokarzinomen des Ösophagus. Forum 2020;35:342-344. [DOI: 10.1007/s12312-020-00825-9] [Reference Citation Analysis]
19 Badgery H, Read M, Winter NN, Taylor ACF, Hii MW. The role of esophagectomy in the management of Barrett's esophagus with high-grade dysplasia. Ann N Y Acad Sci 2020;1481:72-89. [PMID: 32812261 DOI: 10.1111/nyas.14439] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Marques de Sá I, Marcos P, Sharma P, Dinis-Ribeiro M. The global prevalence of Barrett's esophagus: A systematic review of the published literature. United European Gastroenterol J 2020;8:1086-105. [PMID: 32631176 DOI: 10.1177/2050640620939376] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
21 Kahn A, Shaheen NJ, Iyer PG. Approach to the Post-Ablation Barrett's Esophagus Patient. Am J Gastroenterol 2020;115:823-31. [PMID: 31899706 DOI: 10.14309/ajg.0000000000000514] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
22 van der Wel MJ, Coleman HG, Bergman JJGHM, Jansen M, Meijer SL; BOLERO working group. Histopathologist features predictive of diagnostic concordance at expert level among a large international sample of pathologists diagnosing Barrett's dysplasia using digital pathology. Gut 2020;69:811-22. [PMID: 31852770 DOI: 10.1136/gutjnl-2019-318985] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
23 Then EO, Lopez M, Saleem S, Gayam V, Sunkara T, Culliford A, Gaduputi V. Esophageal Cancer: An Updated Surveillance Epidemiology and End Results Database Analysis. World J Oncol 2020;11:55-64. [PMID: 32284773 DOI: 10.14740/wjon1254] [Cited by in Crossref: 76] [Cited by in F6Publishing: 84] [Article Influence: 25.3] [Reference Citation Analysis]
24 Chuy J, Kornblum N. Esophageal Cancer. Geriatric Gastroenterology 2020. [DOI: 10.1007/978-3-319-90761-1_78-1] [Reference Citation Analysis]
25 Petrick JL, Li N, Anderson LA, Bernstein L, Corley DA, El Serag HB, Hardikar S, Liao LM, Liu G, Murray LJ, Rubenstein JH, Schneider JL, Shaheen NJ, Thrift AP, van den Brandt PA, Vaughan TL, Whiteman DC, Wu AH, Zhao WK, Gammon MD, Cook MB. Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium. Cancer 2019;125:4210-23. [PMID: 31490550 DOI: 10.1002/cncr.32444] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
26 Salomao MA, Lam-Himlin D, Pai RK. Substantial Interobserver Agreement in the Diagnosis of Dysplasia in Barrett Esophagus Upon Review of a Patient's Entire Set of Biopsies. Am J Surg Pathol 2018;42:376-81. [PMID: 29135518 DOI: 10.1097/PAS.0000000000000988] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
27 Ghatwary N, Ahmed A, Grisan E, Jalab H, Bidaut L, Ye X. In-vivo Barrett's esophagus digital pathology stage classification through feature enhancement of confocal laser endomicroscopy. J Med Imaging (Bellingham). 2019;6:014502. [PMID: 30840732 DOI: 10.1117/1.jmi.6.1.014502] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
28 Januszewicz W, Tan WK, Lehovsky K, Debiram-Beecham I, Nuckcheddy T, Moist S, Kadri S, di Pietro M, Boussioutas A, Shaheen NJ, Katzka DA, Dellon ES, Fitzgerald RC; BEST1 and BEST2 study investigators. Safety and Acceptability of Esophageal Cytosponge Cell Collection Device in a Pooled Analysis of Data From Individual Patients. Clin Gastroenterol Hepatol 2019;17:647-656.e1. [PMID: 30099104 DOI: 10.1016/j.cgh.2018.07.043] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 11.3] [Reference Citation Analysis]
29 Desai M, Lieberman DA, Kennedy KF, Hamade N, Thota P, Parasa S, Gorrepati VS, Bansal A, Gupta N, Gaddam S, Young PE, Mathur S, Moawad FJ, Cash BD, Sampliner R, Vargo JJ, Falk GW, Sharma P. Increasing prevalence of high-grade dysplasia and adenocarcinoma on index endoscopy in Barrett's esophagus over the past 2 decades: data from a multicenter U.S. consortium. Gastrointest Endosc 2019;89:257-263.e3. [PMID: 30342028 DOI: 10.1016/j.gie.2018.09.041] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
30 Calabrese C, Salice M, Pagano N, Manta R, Rizzello F. Timing and Protocols of Clinical and Endoscopic Surveillance of Barrett’s Esophagus. Revisiting Barrett's Esophagus 2019. [DOI: 10.1007/978-3-319-92093-1_11] [Reference Citation Analysis]
31 Fisher OM, Lord RV. Epidemiology of Barrett Esophagus and Risk Factors for Progression. Shackelford's Surgery of the Alimentary Tract, 2 Volume Set 2019. [DOI: 10.1016/b978-0-323-40232-3.00032-7] [Reference Citation Analysis]
32 Romiti A, Zagari RM. Definition and Epidemiology of Barrett’s Esophagus. Revisiting Barrett's Esophagus 2019. [DOI: 10.1007/978-3-319-92093-1_3] [Reference Citation Analysis]
33 Falk GW, Wani S. Barrett's Esophagus. Clinical Gastrointestinal Endoscopy 2019. [DOI: 10.1016/b978-0-323-41509-5.00025-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Velanovich V. Barrett Esophagus. A Mastery Approach to Complex Esophageal Diseases 2018. [DOI: 10.1007/978-3-319-75795-7_11] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
35 Coleman HG, Xie SH, Lagergren J. The Epidemiology of Esophageal Adenocarcinoma. Gastroenterology 2018;154:390-405. [PMID: 28780073 DOI: 10.1053/j.gastro.2017.07.046] [Cited by in Crossref: 283] [Cited by in F6Publishing: 292] [Article Influence: 56.6] [Reference Citation Analysis]
36 Cavallin F, Scarpa M, Cagol M, Alfieri R, Ruol A, Sileni VC, Ancona E, Castoro C. Esophageal Cancer Clinical Presentation: Trends in the Last 3 Decades in a Large Italian Series. Annals of Surgery 2018;267:99-104. [DOI: 10.1097/sla.0000000000002048] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
37 Kuipers EJ, Spaander MC. Natural History of Barrett's Esophagus. Dig Dis Sci 2018;63:1997-2004. [PMID: 29905908 DOI: 10.1007/s10620-018-5161-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
38 Britton J, Gadeke L, Lovat L, Hamdy S, Hawkey C, Mclaughlin J, Ang Y. Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux disease. The Lancet Gastroenterology & Hepatology 2017;2:824-31. [DOI: 10.1016/s2468-1253(17)30250-9] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
39 Brochard C, Ducancelle A, Pivert A, Bodin M, Ricard A, Coron E, Couffon C, Dib N, Luet D, Musquer N, Rhun ML, Bertrais S, Michalak S, Lunel-Fabiani F, Cesbron-Metivier E, Caroli-Bosc FX. Human papillomavirus does not play a role in the Barrett esophagus: a French cohort. Dis Esophagus 2017;30:1-7. [PMID: 28881904 DOI: 10.1093/dote/dox088] [Reference Citation Analysis]
40 van Putten M, Johnston BT, Murray LJ, Gavin AT, McManus DT, Bhat S, Turkington RC, Coleman HG. 'Missed' oesophageal adenocarcinoma and high-grade dysplasia in Barrett's oesophagus patients: A large population-based study. United European Gastroenterol J 2018;6:519-28. [PMID: 29881607 DOI: 10.1177/2050640617737466] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
41 Huhta H, Helminen O, Palomäki S, Kauppila JH, Saarnio J, Lehenkari PP, Karttunen TJ. Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma. Oncotarget 2017;8:22894-902. [PMID: 28206968 DOI: 10.18632/oncotarget.15284] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
42 Muñoz-Largacha JA, Fernando HC, Litle VR. Optimizing the diagnosis and therapy of Barrett's esophagus. J Thorac Dis 2017;9:S146-53. [PMID: 28446978 DOI: 10.21037/jtd.2017.01.58] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
43 Faccio L, Zaninotto G. Surveillance in Barrett’s Esophagus and Dysplasia. Adenocarcinoma of the Esophagogastric Junction 2017. [DOI: 10.1007/978-3-319-28776-8_3] [Reference Citation Analysis]
44 Gatenby P, Bhattacharjee S, Wall C, Caygill C, Watson A. Risk stratification for malignant progression in Barrett’s esophagus: Gender, age, duration and year of surveillance. World J Gastroenterol 2016; 22(48): 10592-10600 [PMID: 28082811 DOI: 10.3748/wjg.v22.i48.10592] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
45 Snider EJ, Freedberg DE, Abrams JA. Potential Role of the Microbiome in Barrett's Esophagus and Esophageal Adenocarcinoma. Dig Dis Sci 2016;61:2217-25. [PMID: 27068172 DOI: 10.1007/s10620-016-4155-9] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 7.0] [Reference Citation Analysis]
46 Qumseya BJ, Wani S, Desai M, Qumseya A, Bain P, Sharma P, Wolfsen H. Adverse Events After Radiofrequency Ablation in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol 2016;14:1086-1095.e6. [PMID: 27068041 DOI: 10.1016/j.cgh.2016.04.001] [Cited by in Crossref: 102] [Cited by in F6Publishing: 103] [Article Influence: 14.6] [Reference Citation Analysis]
47 Ghaus S, Neumann H, Muhammad H, Tontini GE, Ishaq S. Diagnosis and Surveillance of Barrett's Esophagus: Addressing the Transatlantic Divide. Dig Dis Sci 2016;61:2185-93. [PMID: 27038446 DOI: 10.1007/s10620-016-4138-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
48 To H, Clemons NJ, Duong CP, Trainer AH, Phillips WA. The Genetics of Barrett's Esophagus: A Familial and Population-Based Perspective. Dig Dis Sci 2016;61:1826-34. [PMID: 26971090 DOI: 10.1007/s10620-016-4109-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
49 Asanuma K, Iijima K, Shimosegawa T. Gender difference in gastro-esophageal reflux diseases. World J Gastroenterol 2016; 22(5): 1800-1810 [PMID: 26855539 DOI: 10.3748/wjg.v22.i5.1800] [Cited by in CrossRef: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
50 Ireland CJ, Thompson SK, Laws TA, Esterman A. Risk factors for Barrett’s esophagus: a scoping review. Cancer Causes Control 2016;27:301-23. [DOI: 10.1007/s10552-015-0710-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
51 Rau NB, Berzin TM. Screening and Surveillance of Barrett’s Esophagus. Barrett's Esophagus 2016. [DOI: 10.1016/b978-0-12-802511-6.00006-5] [Reference Citation Analysis]
52 Thomas SJ, Almers L, Schneider J, Graham JE, Havel PJ, Corley DA. Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus. Dig Dis Sci 2016;61:70-9. [PMID: 26396004 DOI: 10.1007/s10620-015-3867-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
53 Seo KI, Park MI, Park SJ, Moon W, Kim SE, Han YJ. Effect of 15 Minutes Brief Education for Medical Personnel in Diagnosing Barrett's Esophagus. Korean J Helicobacter Up Gastrointest Res 2016;16:26. [DOI: 10.7704/kjhugr.2016.16.1.26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
54 Coleman HG, Bhat SK, Murray LJ. Epidemiology and prevalence of Barrett's esophagus. Esophageal cancer and barrett's esophagus 2015. [DOI: 10.1002/9781118655153.ch3] [Reference Citation Analysis]
55 Splittgerber M, Velanovich V. Barrett esophagus. Surg Clin North Am 2015;95:593-604. [PMID: 25965132 DOI: 10.1016/j.suc.2015.02.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
56 Realdon S, Antonello A, Arcidiacono D, Dassie E, Cavallin F, Fassan M, Nardi MT, Alberti A, Rugge M, Battaglia G. Adherence to WCRF/AICR lifestyle recommendations for cancer prevention and the risk of Barrett's esophagus onset and evolution to esophageal adenocarcinoma: results from a pilot study in a high-risk population. Eur J Nutr 2016;55:1563-71. [PMID: 26155779 DOI: 10.1007/s00394-015-0975-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
57 Lindam A, Kendall BJ, Thrift AP, Macdonald GA, O'Brien S, Lagergren J, Whiteman DC. Symptoms of Obstructive Sleep Apnea, Gastroesophageal Reflux and the Risk of Barrett's Esophagus in a Population-Based Case-Control Study. PLoS One 2015;10:e0129836. [PMID: 26090820 DOI: 10.1371/journal.pone.0129836] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
58 Runge TM, Abrams JA, Shaheen NJ. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am 2015;44:203-31. [PMID: 26021191 DOI: 10.1016/j.gtc.2015.02.001] [Cited by in Crossref: 136] [Cited by in F6Publishing: 141] [Article Influence: 17.0] [Reference Citation Analysis]
59 Zhang R, Chen X, Zhang S, Zhang X, Li T, Liu Z, Wang J, Zang W, Wang Y, Du Y, Zhao G. Upregulation of miR-494 Inhibits Cell Growth and Invasion and Induces Cell Apoptosis by Targeting Cleft Lip and Palate Transmembrane 1-Like in Esophageal Squamous Cell Carcinoma. Dig Dis Sci 2015;60:1247-55. [PMID: 25480402 DOI: 10.1007/s10620-014-3433-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
60 Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J, Aldulaimi D, Ho KY, Odze R, Meltzer SJ, Quigley E, Gittens S, Watson P, Zaninotto G, Iyer PG, Alexandre L, Ang Y, Callaghan J, Harrison R, Singh R, Bhandari P, Bisschops R, Geramizadeh B, Kaye P, Krishnadath S, Fennerty MB, Manner H, Nason KS, Pech O, Konda V, Ragunath K, Rahman I, Romero Y, Sampliner R, Siersema PD, Tack J, Tham TC, Trudgill N, Weinberg DS, Wang J, Wang K, Wong JY, Attwood S, Malfertheiner P, MacDonald D, Barr H, Ferguson MK, Jankowski J; BOB CAT Consortium. BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol 2015;110:662-82; quiz 683. [PMID: 25869390 DOI: 10.1038/ajg.2015.55] [Cited by in Crossref: 91] [Cited by in F6Publishing: 92] [Article Influence: 11.4] [Reference Citation Analysis]
61 Kaakoush NO, Castaño-Rodríguez N, Man SM, Mitchell HM. Is Campylobacter to esophageal adenocarcinoma as Helicobacter is to gastric adenocarcinoma? Trends Microbiol 2015;23:455-62. [PMID: 25937501 DOI: 10.1016/j.tim.2015.03.009] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
62 Holt BA, Jayasekeran V, Williams SJ, Lee EY, Bahin FF, Sonson R, Lord RV, Bourke MJ. Early metal stent insertion fails to prevent stricturing after single-stage complete Barrett's excision for high-grade dysplasia and early cancer. Gastrointest Endosc 2015;81:857-64. [PMID: 25442084 DOI: 10.1016/j.gie.2014.08.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
63 Masclee GM, Coloma PM, de Wilde M, Kuipers EJ, Sturkenboom MC. The incidence of Barrett's oesophagus and oesophageal adenocarcinoma in the United Kingdom and The Netherlands is levelling off. Aliment Pharmacol Ther 2014;39:1321-30. [PMID: 24738722 DOI: 10.1111/apt.12759] [Cited by in Crossref: 38] [Cited by in F6Publishing: 28] [Article Influence: 4.2] [Reference Citation Analysis]
64 Kim ES, Lee HY, Lee YJ, Min BR, Choi JH, Park KS, Cho KB, Jang BK, Chung WJ, Hwang JS. Negative impact of sedation on esophagogastric junction evaluation during esophagogastroduodenoscopy. World J Gastroenterol 2014; 20(18): 5527-5532 [PMID: 24833883 DOI: 10.3748/wjg.v20.i18.5527] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
65 Hyland PL, Hu N, Rotunno M, Su H, Wang C, Wang L, Pfeiffer RM, Gherman B, Giffen C, Dykes C, Dawsey SM, Abnet CC, Johnson KM, Acosta RD, Young PE, Cash BD, Taylor PR. Global changes in gene expression of Barrett's esophagus compared to normal squamous esophagus and gastric cardia tissues. PLoS One 2014;9:e93219. [PMID: 24714516 DOI: 10.1371/journal.pone.0093219] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
66 Coleman HG, Bhat SK, Murray LJ, McManus DT, O'Neill OM, Gavin AT, Johnston BT. Symptoms and endoscopic features at barrett's esophagus diagnosis: implications for neoplastic progression risk. Am J Gastroenterol 2014;109:527-34. [PMID: 24589668 DOI: 10.1038/ajg.2014.10] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
67 Kestens C, van Hillegersberg R, Siersema P. Oesofaguscarcinoom. Ontwikkelingen in de oncologie 2014. [DOI: 10.1007/978-90-368-0436-3_24] [Reference Citation Analysis]
68 de Jonge PJ, van Blankenstein M, Grady WM, Kuipers EJ. Barrett's oesophagus: epidemiology, cancer risk and implications for management. Gut 2014;63:191-202. [PMID: 24092861 DOI: 10.1136/gutjnl-2013-305490] [Cited by in Crossref: 88] [Cited by in F6Publishing: 69] [Article Influence: 9.8] [Reference Citation Analysis]
69 Kestens C, van Hillegersberg R, Siersema P. Oesofaguscarcinoom. HUISARTS WETENSCHAP 2014;57:34-38. [DOI: 10.1007/s12445-014-0015-z] [Reference Citation Analysis]
70 Keszei AP, Schouten LJ, Driessen AL, Huysentruyt CJ, Keulemans YC, Goldbohm RA, van den Brandt PA. Vegetable, fruit and nitrate intake in relation to the risk of Barrett's oesophagus in a large Dutch cohort. Br J Nutr 2014;111:1452-62. [PMID: 24308274 DOI: 10.1017/S0007114513003929] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
71 Hofman A, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, Klaver CC, Nijsten TE, Peeters RP, Stricker BH, Tiemeier HW, Uitterlinden AG, Vernooij MW. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 2013;28:889-926. [PMID: 24258680 DOI: 10.1007/s10654-013-9866-z] [Cited by in Crossref: 254] [Cited by in F6Publishing: 267] [Article Influence: 25.4] [Reference Citation Analysis]
72 Edgren G, Adami HO, Weiderpass E, Nyrén O. A global assessment of the oesophageal adenocarcinoma epidemic. Gut 2013;62:1406-14. [PMID: 22917659 DOI: 10.1136/gutjnl-2012-302412] [Cited by in Crossref: 248] [Cited by in F6Publishing: 236] [Article Influence: 24.8] [Reference Citation Analysis]
73 O’Neill OM, Johnston BT, Coleman HG. Achalasia: A review of clinical diagnosis, epidemiology, treatment and outcomes. World J Gastroenterol 2013; 19(35): 5806-5812 [PMID: 24124325 DOI: 10.3748/wjg.v19.i35.5806] [Cited by in CrossRef: 127] [Cited by in F6Publishing: 135] [Article Influence: 12.7] [Reference Citation Analysis]
74 Estores D, Velanovich V. Barrett esophagus: epidemiology, pathogenesis, diagnosis, and management. Curr Probl Surg. 2013;50:192-226. [PMID: 23601575 DOI: 10.1067/j.cpsurg.2013.01.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
75 Parasa S, Sharma P. Complications of gastro-oesophageal reflux disease. Best Pract Res Clin Gastroenterol 2013;27:433-42. [PMID: 23998980 DOI: 10.1016/j.bpg.2013.07.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
76 Behrens A, May A, Manner H, Pohl J, Ell C. [Esophageal precancerous lesions: early diagnosis, treatment, and preservation of quality of life]. Internist (Berl) 2013;54:683-90. [PMID: 23657618 DOI: 10.1007/s00108-012-3212-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
77 Paterson AL, O’Donovan M, Provenzano E, Murray LJ, Coleman HG, Johnson BT, McManus DT, Novelli M, Lovat LB, Fitzgerald RC. Characterization of the timing and prevalence of receptor tyrosine kinase expression changes in oesophageal carcinogenesis. J Pathol. 2013;230:118-128. [PMID: 22733579 DOI: 10.1002/path.4044] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
78 Grant KS, DeMeester SR, Kreger V, Oh D, Hagen JA, Chandrasoma P, DeMeester TR. Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2013;146:31-37. [PMID: 23312980 DOI: 10.1016/j.jtcvs.2012.12.058] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
79 Clemons NJ, Wang DH, Croagh D, Tikoo A, Fennell CM, Murone C, Scott AM, Watkins DN, Phillips WA. Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus. Am J Physiol Gastrointest Liver Physiol 2012;303:G1335-46. [PMID: 23064761 DOI: 10.1152/ajpgi.00291.2012] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
80 Behrens A, Pech O, Ell C. Strategies for identifying dysplasia in Barrett's oesophagus. Diagnostic Histopathology 2012;18:493-497. [DOI: 10.1016/j.mpdhp.2012.10.001] [Reference Citation Analysis]
81 Kendall BJ, Macdonald GA, Hayward NK, Prins JB, O’Brien S, Whiteman DC. The risk of Barrett’s esophagus associated with abdominal obesity in males and females. Int J Cancer. 2013;132:2192-2199. [PMID: 23034724 DOI: 10.1002/ijc.27887] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
82 Bird-Lieberman EL, Dunn JM, Coleman HG, Lao-Sirieix P, Oukrif D, Moore CE, Varghese S, Johnston BT, Arthur K, McManus DT, Novelli MR, O'Donovan M, Cardwell CR, Lovat LB, Murray LJ, Fitzgerald RC. Population-based study reveals new risk-stratification biomarker panel for Barrett's esophagus. Gastroenterology 2012;143:927-35.e3. [PMID: 22771507 DOI: 10.1053/j.gastro.2012.06.041] [Cited by in Crossref: 127] [Cited by in F6Publishing: 135] [Article Influence: 11.5] [Reference Citation Analysis]
83 O'Rorke MA, Cantwell MM, Abnet CC, Brockman AJ, Murray LJ; FINBAR Study Group. Toenail trace element status and risk of Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. Int J Cancer 2012;131:1882-91. [PMID: 22262413 DOI: 10.1002/ijc.27434] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
84 Coleman HG, Bhat S, Johnston BT, McManus D, Gavin AT, Murray LJ. Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett's esophagus. Gastroenterology 2012;142:233-40. [PMID: 22062359 DOI: 10.1053/j.gastro.2011.10.034] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 7.4] [Reference Citation Analysis]
85 Dunki-Jacobs EM, Martin RC. Endoscopic therapy for Barrett's esophagus: a review of its emerging role in optimal diagnosis and endoluminal therapy. Ann Surg Oncol 2012;19:1575-82. [PMID: 22160480 DOI: 10.1245/s10434-011-2163-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]